anonymous
Guest
anonymous
Guest
You bragged about this happening but it's not. Sounds like you need to worry about your customer service in India and your constant backorders.
You bragged about this happening but it's not. Sounds like you need to worry about your customer service in India and your constant backorders.
On the contrary, it looks like J&J is selling Mentor
Trust me. Mentor is in the pole position to be sold. Just wait for the FDA approval.
the FDA doesn't have to approve anything. They are trying to get a better offer from Galderma and if that falls through they are selling to venture capital like they did w Ortho Diagnostics. Venture capital would be a nightmare.
The target is Q3 prior to earnings to mask the false growth from Q4 '15/Q1'16.